Givaudan introduces Novaberin™ at SupplySide Global, responding to growing demand for metabolic health solutions
Clinically researched botanical ingredient offers three-in-one benefit support for metabolic health
Givaudan today announced the launch of Novaberin™, a patent-pending botanical ingredient designed to support metabolic health. Metabolic health refers to how effectively our bodies regulate energy, process nutrients and maintain homeostasis. In a six-month clinical study on Novaberin™ involving adults seeking support for healthy metabolic function1, key outcomes included support for healthy weight management and retaining healthy blood glucose and lipid levels.2 Formulated from Barberry (Berberis aristata), a natural of source berberine, and Amla fruit (Phyllanthus emblica), Novaberin™ delivers a multi-benefit approach in a convenient daily dose of 2 x 250 mg.
As the longevity market evolves, consumers are increasingly viewing metabolic health as a foundation for lifelong wellbeing. Today, 40% are actively using products to support cardiovascular health, metabolic health and weight management.3
“Consumers are increasingly looking for solutions that go beyond weight management alone and support broader metabolic health goals. Novaberin™ offers a clinically researched botanical that mirrors the convenience consumers increasingly expect, while supporting three areas of metabolic health.”
Timothée Olagne, Head of Marketing, Health & Functional Business Unit
Novaberin™ begins with responsibly sourced botanicals from India. The ingredient comes with full traceability and identity documentation to support authenticity and quality assurance. Its carefully monitored origins help build trust in a growing market that is increasingly affected by adulteration concerns.
Suitable for capsules and tablets and available to customers in the US, Novaberin™ is the latest addition to Givaudan’s growing portfolio of science-backed metabolic health solutions.
Supply Side Global visitors to booth 3264 will be able to connect with Givaudan experts to learn more about these ingredients and how they play into the growing longevity market. More information can be found at healthnutritionhub.givaudan.com/ingredients/novaberin.
Publication pending. Novaberin 250 mg twice daily (n=17) vs placebo (n=16); mean change from baseline at day 180, all p<0.05 vs placebo.
Data on file.
NBJ Healthy Aging Report 2026.
About Givaudan
Givaudan is a global leader in Fragrance & Beauty and Taste & Wellbeing. We celebrate the beauty of human experience by creating for happier, healthier lives with love for nature. Together with our customers we deliver food experiences, craft inspired fragrances and develop beauty and wellbeing solutions that make people look and feel good. In 2025, Givaudan employed over 17,500 people worldwide and achieved CHF 7.5 billion in sales with a free cash flow of 14.1%. With a heritage that stretches back over 250 years, we are committed to driving long-term, purpose-led growth by improving people’s health and happiness and increasing our positive impact on nature. This is Givaudan. Human by nature. Discover more at www.givaudan.com.
About Givaudan Taste & Wellbeing
Powered by innovation and creativity, Givaudan Taste & Wellbeing aims to shape the future of food by becoming the co-creation partner of choice to its customers. Built on its global leadership position in flavours and taste, the Company goes beyond to create food experiences that do good and feel good, for body, mind and planet. With an expanded portfolio of products across flavours, taste, functional and nutritional solutions and a deep knowledge of the food ecosystem, Givaudan’s passion is to collaborate with customers and partners to develop game changing innovations in food and beverage. This is Givaudan. Human by nature. Learn more about how we are shaping the future of food at www.givaudan.com/taste-wellbeing
For further information please contact
Rebecca Louis, Head of Communications, Health & Functional
E rebecca.louis@givaudan.com
For further information please contact
Steve Harman, Account Director, Ingredient Communications
E steve@ingredientcommunications.com
Ingredient information is for educational purposes only. These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, mitigate or prevent any disease.
The information provided may or may not be applicable to, or satisfy, all regulatory requirements for all global regions. Specific regulatory requirements must be evaluated to ensure compliance within the individual countries and regions.